Post-Translational Variants of Major Proteins in Amyotrophic Lateral Sclerosis Provide New Insights into the Pathophysiology of the Disease
Authors:
- Léa Bedja-IaconaLBLéa Bedja-Iacona
- Elodie RichardERElodie Richard
- Sylviane MarouillatSMSylviane Marouillat
- Céline BrulardCBCéline Brulard
- Tarek AlouaneTATarek Alouane
- Stéphane BeltranSBStéphane Beltran
- Christian R. AndresCAChristian R. Andres
- Hélène BlascoHélène Blasco
- Philippe CorciaPCPhilippe Corcia
- Charlotte Veyrat-DurebexCVCharlotte Veyrat-Durebex
- Patrick Vourc’hPatrick Vourc’h
Open Access
- 8 August 2024
- journal article
- review article
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 25 (16) , 8664
Abstract
Post-translational modifications (PTMs) affecting proteins during or after their synthesis play a crucial role in their localization and function. The modification of these PTMs under pathophysiological conditions, i.e., their appearance, disappearance, or variation in quantity caused by a pathological environment or a mutation, corresponds to post-translational variants (PTVs). These PTVs can be directly or indirectly involved in the pathophysiology of diseases. Here, we present the PTMs and PTVs of four major amyotrophic lateral sclerosis (ALS) proteins, SOD1, TDP-43, FUS, and TBK1. These modifications involve acetylation, phosphorylation, methylation, ubiquitination, SUMOylation, and enzymatic cleavage. We list the PTM positions known to be mutated in ALS patients and discuss the roles of PTVs in the pathophysiological processes of ALS. In-depth knowledge of the PTMs and PTVs of ALS proteins is needed to better understand their role in the disease. We believe it is also crucial for developing new therapies that may be more effective in ALS.Keywords
This publication has 132 references indexed in Scilit:
- Post‐translational modification sites are present in hydrophilic cavities of alpha‐synuclein, tau, FUS, and TDP‐43 fibrils: A molecular dynamics studyProteins: Structure, Function, and Bioinformatics, 2024
- Selective removal of misfolded SOD1 delays disease onset in a mouse model of amyotrophic lateral sclerosisCellular and Molecular Life Sciences, 2023
- A novel homozygous p.Ser69Pro SOD1 mutation causes severe young-onset ALS with decreased enzyme activityJournal of Neurology, 2022
- Cognitive and behavioral involvement in ALS has been known for more than a centuryNeurological Sciences, 2022
- A role for SUMOylation in the Formation and Cellular Localization of TDP-43 Aggregates in Amyotrophic Lateral SclerosisMolecular Neurobiology, 2019
- Dynactin Deficiency in the CNS of Humans with Sporadic ALS and Mice with Genetically Determined Motor Neuron DegenerationNeurochemical Research, 2013
- Protein aggregation in amyotrophic lateral sclerosisActa Neuropathologica, 2013
- TARDBP variation associated with frontotemporal dementia, supranuclear gaze palsy, and choreaMovement Disorders, 2009
- What Was the Set of Ubiquitin and Ubiquitin-Like Conjugating Enzymes in the Eukaryote Common Ancestor?Journal of Molecular Evolution, 2009
- Phosphorylated TDP‐43 in frontotemporal lobar degeneration and amyotrophic lateral sclerosisAnnals of Neurology, 2008